The global pharmaceutical market is estimated to be worth more than $700 billion. They’re also one of the world’s most profitable industries (with profit as a percentage of revenue).
Yet patent expirations threaten the pharma industry’s profit engine. The US, which boasts some of the world’s most profitable pharma companies, has a big patent cliff coming in 2012. Pharma companies are scrambling to find new drugs, redefine old ones, and sell to new markets to retain their bite of the profit pie.